摘要
目的观察激光光凝术联合和血明目片治疗增殖前期或增殖期糖尿病视网膜病变的疗效。方法 216例(280眼)Ⅲ～Ⅳ期糖尿病视网膜病变患者随机分为2组。135例(175眼)为观察组,行全视网膜光凝术联合和血明目片治疗;81例(105眼)为对照组,单纯行全视网膜光凝术治疗,比较2组疗效。结果治疗3个月后,观察组和对照组视力改善总有效率分别为98.86%和94.28%,视野缺损改善总有效率分别为93.14%和84.77%,水肿、渗出和出血的吸收总有效率分别为97.71%和92.38%,2组比较差异均有统计学意义(P<0.05)。结论激光光凝术联合和血明目片治疗增殖前期或增殖期糖尿病视网膜病变疗效满意。
Objective To observe the effect of retinal photocoagulation combined with Hexue Mingmu tablet on preproliferative or proliferative diabetic retinopathy.Methods A total of 216 patients（280 eyes） with diabetic retinopathy of stage Ⅲ and Ⅳ were randomly divided into the observation group（135 patients,175 eyes） receiving retinal photocoagulation combined with Hexue Mingmu tablet treatment,and control group（81 patients,105 eyes） receiving only photocoagulation treatment.The therapeutic effect was compared between two groups.Results After three postoperative months,the total effective rate was 98.86% and 94.28%,the visual field recovery rate was 93.14% and 84.77%,and effective rate of fundus hemorrhage,edema and exudation was 97.71% and 92.38% in observation group and control group,which showed significant differences between two groups（P0.05）.Conclusion Retinal photocoagulation combined with Hexue Mingmu tablet is safe and effective for preproliferative or proliferative diabetic retinopathy.
出处
《中华实用诊断与治疗杂志》
2012年第1期29-30,共2页
Journal of Chinese Practical Diagnosis and Therapy
关键词
糖尿病视网膜病变
激光光凝术
和血明目片
疗效
Diabetic retinopathy
panretinal photocoagulation
Hexue Mingmu tablet
effect
